Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acquired resistance to crizotinib in advanced lung adenocarcinoma with MET exon 14 skipping.

× No keyword cloud information.

12 in total

Review 1. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.

Authors: Min Yuan; Li-Li Huang; Jian-Hua Chen; Jie Wu; Qing Xu
Journal: Signal Transduct Target Ther Date: 2019-12-17

Review 2. Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations.

Authors: Caiwen Huang; Qihua Zou; Hui Liu; Bo Qiu; Qiwen Li; Yongbin Lin; Ying Liang
Journal: Curr Treat Options Oncol Date: 2020-04-18

3. Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.

Authors: Toshio Fujino; Kenichi Suda; Takamasa Koga; Akira Hamada; Shuta Ohara; Masato Chiba; Masaki Shimoji; Toshiki Takemoto; Junichi Soh; Tetsuya Mitsudomi
Journal: J Hematol Oncol Date: 2022-06-11 Impact factor: 23.168

Review 4. When the MET receptor kicks in to resist targeted therapies.

Authors: Marie Fernandes; Philippe Jamme; Alexis B Cortot; Zoulika Kherrouche; David Tulasne
Journal: Oncogene Date: 2021-05-24 Impact factor: 9.867

Review 5. Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement.

Authors: Xing Huang; Enliang Li; Hang Shen; Xun Wang; Tianyu Tang; Xiaozhen Zhang; Jian Xu; Zengwei Tang; Chengxiang Guo; Xueli Bai; Tingbo Liang
Journal: Front Cell Dev Biol Date: 2020-05-06

Review 6. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.

Authors: Min Yuan; Li-Li Huang; Jian-Hua Chen; Jie Wu; Qing Xu
Journal: Signal Transduct Target Ther Date: 2019-12-17

Review 7. A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations.

Authors: Mariacarmela Santarpia; Marco Massafra; Vittorio Gebbia; Antonio D'Aquino; Claudia Garipoli; Giuseppe Altavilla; Rafael Rosell
Journal: Transl Lung Cancer Res Date: 2021-03

Review 8. Targeting HGF/c-MET Axis in Pancreatic Cancer.

Authors: Srinivasa P Pothula; Zhihong Xu; David Goldstein; Romano C Pirola; Jeremy S Wilson; Minoti V Apte
Journal: Int J Mol Sci Date: 2020-12-01 Impact factor: 5.923

Review 9. Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer.

Authors: Takamasa Koga; Kenichi Suda; Tetsuya Mitsudomi
Journal: Cancer Sci Date: 2022-01-23 Impact factor: 6.716

Review 10. Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges.

Authors: Toshio Fujino; Kenichi Suda; Tetsuya Mitsudomi
Journal: Lung Cancer (Auckl) Date: 2021-05-20